| T33711L |
Nolomirole HCl
|
138531-51-8
|
100%
|
|
|
Nolomirole HCl (CHF 1035) is a novel selective dopamine agonist with oral activity and inhibitory effects on norepinephrine release, which can be used to study m...
|
| T6648 |
Rotundine
|
483-14-7
|
100%
|
|
|
Rotundine (Gindarine) (L-tetrahydropalmatine, L-THP) is a selective dopamine D1 receptor antagonist with IC50 of 166 nM.
|
| T7943 |
Fluphenazine decanoate
|
5002-47-1
|
100%
|
|
|
Fluphenazine decanoate is dopamine D2 receptor blocke,and is a long-acting phenothiazine neuroleptic that used to treat schizophrenia.
|
| T1180 |
Blonanserin
|
132810-10-7
|
100%
|
|
|
Blonanserin (AD-5423) is an atypical antipsychotic approved in Japan in January, 2008. Relative to many other antipsychotics, blonanserin has an improved tolerab...
|
| T1993 |
J-147
|
1146963-51-0
|
100%
|
|
|
J-147 is an experimental drug with reported effects against both Alzheimer's disease and ageing in mouse models of accelerated aging. It is a curcumin derivative...
|
| T6398 |
Azaperone
|
1649-18-9
|
100%
|
|
|
Azaperone (Fluoperidol) is a pyridinylpiperazine and butyrophenone neuroleptic drug with sedative and antiemetic effects, which is used mainly as a tranquilizer ...
|
| T71707L |
Romergoline 2HCl
|
|
100%
|
|
|
Romergoline 2HCl is a D1 agonist and D2 antagonist used in the study of Parkinson's disease.
|
| T1175 |
Bromopride
|
4093-35-0
|
100%
|
|
|
Bromopride (Valopride) is a dopamine antagonist with prokinetic properties closely related to metoclopramide, and is widely used as an antiemetic. It is not avai...
|
| T67729 |
UCM-1306
|
2258608-78-3
|
100%
|
|
|
UCM-1306 is a potent and orally active allosteric modulator (PAM) of human dopamine D1 receptor. UCM-1306 could increase the maximal effect of endogenous dopamin...
|
| T14083 |
Abaperidone
|
183849-43-6
|
94.35%
|
|
|
Abaperidone is a potent 5-HT2A receptor and dopamine D2 receptor antagonist with an IC50 of 6.2 for 5-HT2A receptors and 17 nM for dopamine D2 receptors.Abaperid...
|
| T0185 |
Escitalopram
|
128196-01-0
|
94.62%
|
|
|
Escitalopram (Seroplex) is a furancarbonitrile that is one of the SEROTONIN UPTAKE INHIBITORS used as an antidepressant. The drug is also effective in reducing e...
|
| T24047 |
Etilevodopa hydrochloride
|
39740-30-2
|
95.00%
|
|
|
Etilevodopa hydrochloride (L-DOPA ethyl ester) is a prodrug of levodopa. It also has greater gastric solubility and significant brain penetration.
|
| T7352 |
Pridopidine
|
346688-38-8
|
95.2%
|
|
|
Pridopidine (FR310826), a dopamine (DA) stabilizer, acts as a low affinity dopamine D2 receptor (D2R) antagonist, improves motor performance and shows neuroprote...
|
| T12352 |
Oxidopamine hydrochloride
|
28094-15-7
|
96.17%
|
|
|
Oxidopamine hydrochloride (6-Hydroxydopamine hydrochloride) is an neurotransmitter dopamine antagonist.
|
| T15461 |
Halopemide
|
59831-65-1
|
96.29%
|
|
|
Halopemide is a potent inhibitor of PLD (IC50 = 220 and 310 nM for human PLD1 and PLD2). Halopemid is an antagonist of dopamine receptors. Halopemid can be used ...
|
| T35841 |
5-Benzyloxygramine
|
1453-97-0
|
96.33%
|
|
|
5-Benzyloxygramine is a N protein PPI orthosteric stabilizer that exhibits both antiviral and N-NTD protein-stabilizing activities[1].
5-benzyloxygramine stabili...
|
| T11799 |
L-745870 hydrochloride
|
1173023-36-3
|
97.36%
|
|
|
L-745870 hydrochloride has excellent brain penetration. L-745870 hydrochloride is a high-affinity, selective and orally active human dopamine D4 receptor antagon...
|
| T3046 |
BMY 7378 dihydrochloride
|
21102-95-4
|
97.67%
|
|
|
BMY 7378 dihydrochloride (BMY7378 HCl) , α1D-adrenergic receptor antagonist, is a weak partial agonist/antagonist of 5-HT1A receptor.
|
| T10683 |
Carmoxirole hydrochloride
|
115092-85-8
|
97.8%
|
|
|
Carmoxirole hydrochloride (EMD 45609 hydrochloride) is a selective dopamine D2 receptor agonist with antihypertensive activity in vivo.
|
| TQ0084 |
Lumateperone Tosylate
|
1187020-80-9
|
98%
|
|
|
lumateperone Tosylate (ITI-007) is a 5-HT2A receptor antagonist (Ki: 0.54 nM), a SERT blocker (Ki: 61 nM), a partial agonist of presynaptic D2 receptors and an a...
|
